Navigation Links
Amgen introduces comprehensive financial assistance programs for cancer patients

Amgen today announced AmgenTM Oncology Assistance (AOA), a comprehensive, multi-faceted financial assistance program that will include a "cap" on out-of-pocket co-payments for cancer patients receiving VectibixTM (panitumumab). Through AOA, patients who are uninsured, underinsured, or unable to afford their insurance co-payments will receive help obtaining financial support for Amgen's cancer medicines.

"We recognize that treating cancer is expensive and our industry needs to find new ways to ease the financial burden on cancer patients, their families and society," said Kevin Sharer, chairman and chief executive officer at Amgen. "Our goal is to create the most comprehensive oncology access program in the industry, and we are starting with Amgen Oncology Assistance. To ensure patients have access to Vectibix, we have priced it at approximately 20 percent less than the other antibody on the market and created the Vectibix Cap, which is the first of its kind for colorectal cancer patients."

The AOA program will be available for U.S. cancer patients and will launch in October. AOA will expand and consolidate the company's existing financial assistance programs into a simplified package with a single gateway:

  • The new Vectibix Cap will limit total patient co-payments for Vectibix in the United States, regardless of income or insurance status. Once a patient reaches the cap (five percent of their adjusted gross income), he or she will become eligible for the SAFETY NET® Foundation.
  • The SAFETY NET Foundation is a well-established patient assistance program that provides Amgen oncology medicines at no cost to qualifying uninsured patients. Available to patients with household adjusted gross incomes of up to $75,000 per year, The SAFETY NET Foundation is one of the most generous oncology product donation programs in the industry.
  • Amgen also donates millions of dollars to independent third-p arty administered patient assistance programs to help reduce the financial burden for uninsured or low-income patients.

These programs build on Amgen's Reimbursement Connection®, which has been addressing the provider community's reimbursement questions regarding Amgen therapies for more than 15 years. For more information about Amgen Oncology Assistance, please visit www.amgen.com.


'"/>

Source:Porter Novelli


Related biology news :

1. Agilent Technologies introduces advanced zebrafish, mouse microarrays for stem cell and developmental biology research
2. Agilent Technologies introduces high-capacity human protein removal system for proteomics research
3. A comprehensive response to HIV could prevent 10 million AIDS deaths in Africa by 2020
4. Lipids get new comprehensive classification system
5. NIH launches comprehensive effort to explore cancer genomics
6. RNA map provides first comprehensive understanding of alternative splicing
7. LIAI completes worlds most comprehensive analysis on influenza virus data
8. Costly breeding programs for endangered species pay off
9. Investment level in HIV prevention programs related to HIV incidence in the United States
10. Viral DNA sequence a possible trigger for breast cancer
11. Enzyme, lost in most mammals, is shown to protect against UV-induced skin cancer
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/7/2017)... England , March 7, 2017 Brandwatch , ... chosen by The Prince,s Trust to uncover insights to ... across The Trust. The UK,s leading youth charity will ... social campaign results and get a better understanding of the topics ... ...
(Date:3/2/2017)... Summary This report provides all ... and its partnering interests and activities since 2010. ... The Partnering Deals and Alliance since 2010 report provides ... of the world,s leading life sciences companies. ... ensure inclusion of the most up to date deal ...
(Date:2/28/2017)... --  Acuant , a leading provider of data capture ... new and core technologies building upon the acquisition of ... desktop Acuant FRM TM facial recognition and match ... manual review of identity documents by accredited professionals. ... most accurate capture software to streamline workflows by securely ...
Breaking Biology News(10 mins):
(Date:3/29/2017)... -  GeneNews Limited (TSX:GEN) ("GeneNews" or the "Company") announced ... stratification test for breast cancer, via its Virginia ... incorporates a blood-based biomarker test with a sophisticated algorithm to ... cancer.   ... BreastSentry measures the fasting plasma levels of two biomarkers ...
(Date:3/28/2017)... ... March 28, 2017 , ... ... the Advancement of Science (AAAS), the world's largest general scientific society and ... high-impact scholarly collection across its cross-platform reference management system. , All six ...
(Date:3/28/2017)... (PRWEB) , ... March 28, 2017 , ... Franz ... flagship product, AllegroGraph , has been named a ‘Champion’ by Bloor Research in ... the highest ranked product in its class, and, thanks to Gruff, it was rated ...
(Date:3/28/2017)... , ... March 28, 2017 , ... ... members of the Modular Building Institute (MBI), an international modular trade organization, were ... permanent modular category for the Pagliuca Life Lab at Harvard University. The awards ...
Breaking Biology Technology: